---
title: >-
  Effect of Cannabidiol on Antiseizure Medication Cycling, Polypharmacy, and
  Healthcare Resource Utilisation in Patients With Dravet Syndrome,
  Lennox-Gastaut Syndrome, or Tuberous Sclerosis Complex: Real-World Data from a
  US Claims Analysis
description: >-
  Explore this publication on real-world evidence: Effect of Cannabidiol on
  Antiseizure Medication Cycling, Polypharmacy, and Healthcare Resource
  Utilisation in…
date: '2025-01-01'
category: Publications
tags:
  - Jazz Pharmaceuticals
  - Poster Presentation
  - Approval & Commercialization
  - 'No'
  - R&D
canonical_url: >-
  https://www.headwaterscience.com/resources/publications/ind-jazz-pharmaceuticals/effect-of-cannabidiol-on-antiseizure-medication-cycling/
source: Headwater
license: © 2026 Headwater. All rights reserved.
slug: effect-of-cannabidiol-on-antiseizure-medication-cycling
id: Xw2uT6fI9wE7rDM2mzwXd
contentType: article
---

## Challenge

CBD had demonstrated ASM cycle reduction and polypharmacy benefits in controlled trials, but real-world evidence on the magnitude and sustainability of these effects in routine clinical practice was lacking.

## Solution

Target RWE researchers analyzed real-world data to estimate the effect of CBD on antiseizure medication cycling, polypharmacy burden, and healthcare resource utilization in epilepsy patients, funded by Jazz Pharmaceuticals.